BioCatalyst

Sacituzumab Govitecan-hziy (SG), Pembrolizumab, Carboplatin, Cisplatin — catalyst calendar

1 verified catalyst event(s) referencing Sacituzumab Govitecan-hziy (SG), Pembrolizumab, Carboplatin, Cisplatin, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participa
Phase 2 · Non-small Cell Lung Cancer
 GILD GILEAD SCIENCES, INC. Sacituzumab Govitecan-hziy (SG), Pembrol ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.